Home Tests Beta-Amyloid 42/40 Ratio and Apolipoprotein E (APOE) Isoform Panel, CSF (Q94628)

Beta-Amyloid 42/40 Ratio and Apolipoprotein E (APOE) Isoform Panel, CSF (Q94628)

Ishbiliah , Riyadh - 145KM

Assesses genetic risk for Alzheimer’s disease and identifies adults eligible for anti-amyloid monoclonal antibody therapy. Measures Beta-Amyloid 42/40 Ratio, ApoE Isoform, and Total ApoE in CSF using LC/MS/MS assays. An algorithm calculates a risk score categorizing patients as Low, Intermediate, or High risk of AD.